Jaume Jorba

Medicine · Health Sciences

33h-index4.2kcitations85works13.22yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Viral Infections and Immunology Research(76), Viral gastroenteritis research and epidemiology(65), Whipple's Disease and Interleukins(16), SARS-CoV-2 and COVID-19 Research(13), Respiratory viral infections research(13)

Publications85 total

<i>Notes from the Field</i>: Detection of Vaccine-Derived Poliovirus Type 2 in Wastewater — Five European Countries, September–December 2024
MMWR Morbidity and Mortality Weekly Report·2025· 3 citedOpen Access
Environmental Drivers of Taxonomic, Functional, and Phylogenetic Diversity in Temperate Forest Ecosystems
SSRN Electronic Journal·2025Open Access
Complete genome sequences of nine double recombinant vaccine-derived novel oral poliovirus type 2 genomes from Nigeria 2023–2024
Microbiology Resource Announcements·2024· 4 citedOpen Access
Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, January 2023–June 2024
MMWR Morbidity and Mortality Weekly Report·2024· 45 citedOpen Access
Complete genome sequences of six S19 poliovirus reference strains
Microbiology Resource Announcements·2024· 4 citedOpen Access
Surveillance To Track Progress Toward Polio Eradication — Worldwide, 2022–2023
MMWR Morbidity and Mortality Weekly Report·2024· 23 citedOpen Access
<i>Notes from the Field</i>: Circulating Vaccine-Derived Poliovirus Type 2 Emergences Linked to Novel Oral Poliovirus Vaccine Type 2 Use — Six African Countries, 2021–2023
MMWR Morbidity and Mortality Weekly Report·2023· 24 citedOpen Access
Progress Toward Poliomyelitis Eradication — Afghanistan, January 2022–June 2023
MMWR Morbidity and Mortality Weekly Report·2023· 14 citedOpen Access
Progress Toward Poliomyelitis Eradication — Pakistan, January 2022–June 2023
MMWR Morbidity and Mortality Weekly Report·2023· 21 citedOpen Access
Molecular Epidemiology
ClinMicroNow·2023
Surveillance To Track Progress Toward Poliomyelitis Eradication — Worldwide, 2021–2022
MMWR Morbidity and Mortality Weekly Report·2023· 14 citedOpen Access
Update on Wild Poliovirus Type 1 Outbreak — Southeastern Africa, 2021–2022
MMWR Morbidity and Mortality Weekly Report·2023· 15 citedOpen Access
Update on Vaccine-Derived Poliovirus Outbreaks — Worldwide, January 2021–December 2022
MMWR Morbidity and Mortality Weekly Report·2023· 49 citedOpen Access
Vaccine-derived poliovirus serotype 2 outbreaks and response in the Democratic Republic of the Congo, 2017–2021
Vaccine·2023· 9 citedOpen Access
Assessing country compliance with circulating vaccine-derived poliovirus type 2 outbreak response standard operating procedures: April 2016 to December 2020
Vaccine·2023· 11 citedOpen Access
Genetic and epidemiological description of an outbreak of circulating vaccine-derived polio-virus type 2 (cVDPV2) in Angola, 2019–2020
Vaccine·2023· 4 citedOpen Access
Nearly Complete Genome Sequences of Type 2 Sabin-Like Polioviruses from Northern Nigerian Poliovirus Surveillance, 2016 to 2018
Microbiology Resource Announcements·2022Open Access
Progress Toward Poliomyelitis Eradication ― Afghanistan, January 2021–September 2022
MMWR Morbidity and Mortality Weekly Report·2022· 19 citedOpen Access
Wastewater Testing and Detection of Poliovirus Type 2 Genetically Linked to Virus Isolated from a Paralytic Polio Case — New York, March 9–October 11, 2022
MMWR Morbidity and Mortality Weekly Report·2022· 78 citedOpen Access
Progress Toward Poliomyelitis Eradication — Pakistan, January 2021–July 2022
MMWR Morbidity and Mortality Weekly Report·2022· 24 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Cara C. Burns(22), Ousmane M. Diop(18), Steven G.F. Wassilak(13), Olen M. Kew(11), Elizabeth Henderson(11), Jane Iber(9), Mark A. Pallansch(7), Derek Ehrhardt(7), M. Steven Oberste(6), Chukwuma Mbaeyi(6), Jamal Ahmed(6), Hiroyuki Shimizu(5), Raymond P. Campagnoli(5), Eric Wiesen(5), Tracie J. Gardner(5), Hamid Jafari(5), Jing Shaw(4), Roland W. Sutter(4), Omotayo Bolu(4), Smita Chavan(4)